rs1555535403
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM4PP3PP5_Moderate
The NM_001042492.3(NF1):c.7076_7102del(p.Val2359_Leu2367del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. V2359V) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 32)
Consequence
NF1
NM_001042492.3 inframe_deletion
NM_001042492.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.18
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM4
?
Nonframeshift variant in NON repetitive region in NM_001042492.3.
PP3
?
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
?
Variant 17-31343020-AGTATTTATGGCAATCCGGAATCCTCTG-A is Pathogenic according to our data. Variant chr17-31343020-AGTATTTATGGCAATCCGGAATCCTCTG-A is described in ClinVar as [Pathogenic]. Clinvar id is 522586.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.7076_7102del | p.Val2359_Leu2367del | inframe_deletion | 48/58 | ENST00000358273.9 | |
NF1 | NM_000267.3 | c.7013_7039del | p.Val2338_Leu2346del | inframe_deletion | 47/57 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NF1 | ENST00000358273.9 | c.7076_7102del | p.Val2359_Leu2367del | inframe_deletion | 48/58 | 1 | NM_001042492.3 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fan Lab, Zhengzhou University | Jul 12, 2017 | The c.7013_7039del mutation in NF1 gene, resulting p.Val2338_Leu2346del in the amino acid sequence of NF1 protein, has not been reported in patient with Neurofibromatosis type 1 yet. According to the functional prediction and two-generation pedigree analysis, this mutation was consider to be pathogenic in our case. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at